Therefore, identifying and understanding the molecular functions of genes responsible for the control of fat metabolism and insulin sensitivity holds great promise for the development of pharmaceutical interventions for obesity and diabetes related health problems. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.